This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2011 Jun;21(6):350-6.

doi: 10.1097/FPC.0b013e32833ee605.

PharmGKB summary: dopamine receptor D2

Huaiyu Mi¹, Paul D Thomas, Huijun Z Ring, Ruhong Jiang, Katrin Sangkuhl, Teri E Klein, Russ B Altman

Affiliations

PMID: 20736885
PMCID: PMC3091980
DOI: 10.1097/FPC.0b013e32833ee605

PharmGKB summary: dopamine receptor D2

Huaiyu Mi et al. Pharmacogenet Genomics. 2011 Jun.

. 2011 Jun;21(6):350-6.

doi: 10.1097/FPC.0b013e32833ee605.

Authors

Huaiyu Mi¹, Paul D Thomas, Huijun Z Ring, Ruhong Jiang, Katrin Sangkuhl, Teri E Klein, Russ B Altman

Affiliation

¹ Evolutionary Systems Biology, Artificial Intelligence Center, SRI International, Menlo Park, California, USA.

PMID: 20736885
PMCID: PMC3091980
DOI: 10.1097/FPC.0b013e32833ee605

No abstract available

PubMed Disclaimer

Similar articles

Dopamine D2 receptor promoter polymorphism: no association with schizophrenia.
Tallerico T, Ulpian C, Liu IS. Tallerico T, et al. Psychiatry Res. 1999 Feb 22;85(2):215-9. doi: 10.1016/s0165-1781(98)00125-5. Psychiatry Res. 1999. PMID: 10220012 Clinical Trial.
Lack of association between two dopamine D2 receptor gene polymorphisms and schizophrenia.
Caprini S, Saetre P, Melle I, Djurovic S, Andreassen OA, Skjødt C, Duong L, Werge T, Hall H, Agartz I, Terenius L, Jönsson EG. Caprini S, et al. Psychiatr Genet. 2011 Aug;21(4):214-5. doi: 10.1097/YPG.0b013e328341e020. Psychiatr Genet. 2011. PMID: 21712758 No abstract available.
Association between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia.
Jönsson EG, Nöthen MM, Neidt H, Forslund K, Rylander G, Mattila-Evenden M, Asberg M, Propping P, Sedvall GC. Jönsson EG, et al. Schizophr Res. 1999 Nov 9;40(1):31-6. doi: 10.1016/s0920-9964(99)00033-x. Schizophr Res. 1999. PMID: 10541004
-141C insertion/deletion polymorphism of the dopamine D2 receptor gene is associated with schizophrenia in Chinese Han population: Evidence from an ethnic group-specific meta-analysis.
Zhao X, Huang Y, Chen K, Li D, Han C, Kan Q. Zhao X, et al. Asia Pac Psychiatry. 2016 Sep;8(3):189-98. doi: 10.1111/appy.12206. Epub 2015 Sep 7. Asia Pac Psychiatry. 2016. PMID: 26346037 Review.
Dopamine receptor polymorphisms and drug response in schizophrenia.
Scharfetter J. Scharfetter J. Pharmacogenomics. 2001 Aug;2(3):251-61. doi: 10.1517/14622416.2.3.251. Pharmacogenomics. 2001. PMID: 11535113 Review.

See all similar articles

Cited by

History of the dopamine hypothesis of antipsychotic action.
Seeman MV. Seeman MV. World J Psychiatry. 2021 Jul 19;11(7):355-364. doi: 10.5498/wjp.v11.i7.355. eCollection 2021 Jul 19. World J Psychiatry. 2021. PMID: 34327128 Free PMC article. Review.
Impact of the DRD2 Polymorphisms on the Effectiveness of the Training Program.
Świtała K, Bojarczuk A, Hajto J, Piechota M, Buryta M, Leońska-Duniec A. Świtała K, et al. Int J Environ Res Public Health. 2022 Apr 19;19(9):4942. doi: 10.3390/ijerph19094942. Int J Environ Res Public Health. 2022. PMID: 35564336 Free PMC article.
Databases in the area of pharmacogenetics.
Sim SC, Altman RB, Ingelman-Sundberg M. Sim SC, et al. Hum Mutat. 2011 May;32(5):526-31. doi: 10.1002/humu.21454. Epub 2011 Apr 5. Hum Mutat. 2011. PMID: 21309040 Free PMC article. Review.
Posttraumatic Brain Injury Cognitive Performance Is Moderated by Variation Within ANKK1 and DRD2 Genes.
Failla MD, Myrga JM, Ricker JH, Dixon CE, Conley YP, Wagner AK. Failla MD, et al. J Head Trauma Rehabil. 2015 Nov-Dec;30(6):E54-66. doi: 10.1097/HTR.0000000000000118. J Head Trauma Rehabil. 2015. PMID: 25931179 Free PMC article.
The pharmacogenomics of severe traumatic brain injury.
Adams SM, Conley YP, Wagner AK, Jha RM, Clark RS, Poloyac SM, Kochanek PM, Empey PE. Adams SM, et al. Pharmacogenomics. 2017 Oct;18(15):1413-1425. doi: 10.2217/pgs-2017-0073. Epub 2017 Oct 4. Pharmacogenomics. 2017. PMID: 28975867 Free PMC article. Review.

See all "Cited by" articles

References

1. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. Dopamine receptors: from structure to function. Physiol Rev. 1998;78:189–225. - PubMed
1. Filopanti M, Lania AG, Spada A. Pharmacogenetics of D2 dopamine receptor gene in prolactin-secreting pituitary adenomas. Expert Opin Drug Metab Toxicol. 2010;6:43–53. - PubMed
1. Kidd KK, Morar B, Castiglione CM, Zhao H, Pakstis AJ, Speed WC, et al. A global survey of haplotype frequencies and linkage disequilibrium at the DRD2 locus. Hum Genet. 1998;103:211–227. - PubMed
1. Le Crom S, Kapsimali M, Barome PO, Vernier P. Dopamine receptors for every species: gene duplications and functional diversification in Craniates. J Struct Funct Genomics. 2003;3:161–176. - PubMed
1. Callier S, Snapyan M, Le Crom S, Prou D, Vincent JD, Vernier P. Evolution and cell biology of dopamine receptors in vertebrates. Biol Cell. 2003;95:489–502. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Molecular Biology Databases
- Pharmacogenomics Knowledge Base